T1	Participants 62 101	laryngopharyngeal epidermoid carcinoma.
T2	Participants 136 216	Twenty-four patients, with a biopsy-proven laryngeal or hypopharyngeal carcinoma
T3	Participants 538 560	healthy control-group.
T4	Participants 611 650	patients with laryngo-pharyngeal cancer
